A paraprobiotic is a bacterial product that has been deliberately killed before it is swallowed. The cells in this one were heated to 90 degrees for half an hour and then freeze dried, so, as the authors put it, it is not expected to replicate or stably colonise the gut. The idea is that the dead cells and their components can still be sensed by the host even though nothing takes up residence.
Drawn from the paper's introduction.
The authors write that baseline gut microbial diversity may represent a reproducible stratification marker for paraprobiotic responsiveness, but that this proposition has not been comprehensively evaluated in controlled trial settings.
Drawn from the paper's introduction.
One hundred and twenty overweight Korean adults were randomised 60 to each arm and took either a 1,600 mg daily sachet containing 1,500 mg of the heat inactivated preparation or a matching placebo for twelve weeks. The trial was registered in advance and powered for its primary outcome: 50 participants per group were required to detect a 1.5 kg between group difference in body fat mass at two sided alpha 0.05 with 90 percent power.
The primary outcome came back null. Change in total body fat mass by DXA showed no significant between group difference across the per protocol population, with fat mass falling in both arms. Body weight fell by 1.33 plus or minus 0.28 kg on the supplement against 0.94 plus or minus 0.26 kg on placebo, which was not statistically significant.
Splitting participants by how diverse their gut community had been at the start produced a different picture. In the low diversity subgroup, body weight fell by 1.98 plus or minus 0.39 kg against 0.95 plus or minus 0.33 kg on placebo at p 0.0483, with BMI at p 0.0412, circulating leptin at p 0.0423 and HDL cholesterol at p 0.0342. The high diversity subgroup showed no consistent response across any outcome domain. Each subgroup contained between 24 and 26 people.
The clinical changes in the low diversity subgroup were accompanied by compositional shifts in the gut community, elevated faecal acetate and butyrate and altered bile acid composition, with changes in the relative abundance of particular taxa inversely correlated with changes in body weight, body fat mass and leptin.
All six authors are affiliated with the LOTTE R and D Center, and the sponsor is LOTTE Chilsung Beverage.
| Primary outcome, change in total body fat mass by DXA over 12 weeks | no significant between group difference; fat mass fell in both arms |
| Body weight, whole per protocol population | minus 1.33±0.28 kg supplement vs minus 0.94±0.26 kg placebo, not significant |
| Low diversity subgroup, body weight | minus 1.98±0.39 kg vs minus 0.95±0.33 kg, p=0.0483 |
| Low diversity subgroup, other outcomes | BMI p=0.0412; leptin p=0.0423; HDL cholesterol p=0.0342 |
| Randomisation and analysis sets | 120 randomised (60 per group); per protocol 101 (49 vs 52); subgroups 24 to 26 each |
| Dose | one 1,600 mg sachet daily containing 1,500 mg heat inactivated preparation |
| Powering | 50 per group for a 1.5 kg between group fat mass difference at alpha 0.05, 90% power |
| Registration | CRIS KCT0008119, no protocol amendments after registration |
| Sponsor | LOTTE Chilsung Beverage; all six authors affiliated with LOTTE R and D Center |
Proposed by the authors This is the explanation the authors offer in their discussion. This study did not test it.
The authors argue that communities with low diversity harbour a less densely occupied niche, a condition which permits broader and more coherent compositional reorganization in response to external stimuli, whereas species rich communities are less susceptible to reorganization because the constituent taxa use limited resources more efficiently and collectively occupy a denser network of nutritional niches.
They are explicit that their own evidence for this is indirect. They write that the observed cross domain coherence provides indirect support for the possibility that the supplement contributed to reshaping the resident microbial community, rather than evidence of a strain specific causal mechanism, and that the correlations do not establish temporal sequence, mediation, or causality.
Drawn from Discussion, PMC13523931.
A properly powered trial of a killed bacterial supplement found nothing on its pre-specified primary outcome, and the only signals appeared in a subgroup defined by how diverse someone's gut was to begin with.
Korean adults aged 19 to 65 with a body mass index between 25 and 30, over twelve weeks.
A trial that measures baseline diversity first and randomises within those strata, designed by a group with no commercial stake, is what would turn this from a hypothesis into a finding.
Newsletter
Each issue by email, when the newsletter launches. Leaving your address puts you on the list, nothing is sent yet.